@article{pett_prescription_2020,
	title = {Prescription drug monitoring program use and utility by {Washington} {State} pharmacists: {A} mixed-methods study},
	volume = {60},
	issn = {1544-3450},
	shorttitle = {Prescription drug monitoring program use and utility by {Washington} {State} pharmacists},
	doi = {10.1016/j.japh.2019.09.016},
	abstract = {OBJECTIVES: To explore factors and situations that influence pharmacists to use the prescription drug monitoring program (PDMP) and to characterize actions taken by pharmacists after alarming scenarios from a PDMP query.
DESIGN: Explanatory sequential 2-phase mixed-methods design: (1) cross-sectional Web-based survey of Washington State pharmacists followed by (2) interviews with purposefully selected respondents to explore statistically significant quantitative findings.
SETTING AND PARTICIPANTS: The study was conducted in Washington State from September 2018 to February 2019. A total of 967 Washington State pharmacists from various practice settings, including inpatient and outpatient pharmacies, participated. Ten outpatient pharmacists were interviewed in the second phase.
OUTCOME MEASURES: The pharmacists reported the frequency of PDMP use, opinion on the usefulness of PDMP, and action(s) taken after a concerning PDMP report.
RESULTS: The usable response rate for pharmacists with a PDMP account was 17.6\% (818/4659), and usable response rate for all pharmacists was 10.4\% (967/9263). PDMP use varied by race, practice setting, and employer policy on PDMP use. Among the 818 PDMP users, 396 (48\%) used the database at least once during a shift. Frequent PDMP users were more likely to recommend naloxone compared with less frequent users (adjusted odds ratio 1.70 [95\% CI 1.09-2.65], P = 0.02). The following 3 interview themes were identified: time, company policy, and red flags.
CONCLUSION: PDMP has value to pharmacists of all practice settings studied. Frequent PDMP use may facilitate more pharmacist interventions, such as a naloxone prescription.},
	language = {eng},
	number = {1},
	journal = {Journal of the American Pharmacists Association: JAPhA},
	author = {Pett, Ryan G. and Mancl, Lloyd and Revere, Debra and Stergachis, Andy},
	month = feb,
	year = {2020},
	pmid = {31753615},
	keywords = {Adult, Controlled Substances, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Pharmacists, Prescription Drug Monitoring Programs, Washington, Young Adult},
	pages = {57--65},
}

{"_id":"ZuPtTAcFoTaWyxANh","bibbaseid":"pett-mancl-revere-stergachis-prescriptiondrugmonitoringprogramuseandutilitybywashingtonstatepharmacistsamixedmethodsstudy-2020","author_short":["Pett, R. G.","Mancl, L.","Revere, D.","Stergachis, A."],"bibdata":{"bibtype":"article","type":"article","title":"Prescription drug monitoring program use and utility by Washington State pharmacists: A mixed-methods study","volume":"60","issn":"1544-3450","shorttitle":"Prescription drug monitoring program use and utility by Washington State pharmacists","doi":"10.1016/j.japh.2019.09.016","abstract":"OBJECTIVES: To explore factors and situations that influence pharmacists to use the prescription drug monitoring program (PDMP) and to characterize actions taken by pharmacists after alarming scenarios from a PDMP query. DESIGN: Explanatory sequential 2-phase mixed-methods design: (1) cross-sectional Web-based survey of Washington State pharmacists followed by (2) interviews with purposefully selected respondents to explore statistically significant quantitative findings. SETTING AND PARTICIPANTS: The study was conducted in Washington State from September 2018 to February 2019. A total of 967 Washington State pharmacists from various practice settings, including inpatient and outpatient pharmacies, participated. Ten outpatient pharmacists were interviewed in the second phase. OUTCOME MEASURES: The pharmacists reported the frequency of PDMP use, opinion on the usefulness of PDMP, and action(s) taken after a concerning PDMP report. RESULTS: The usable response rate for pharmacists with a PDMP account was 17.6% (818/4659), and usable response rate for all pharmacists was 10.4% (967/9263). PDMP use varied by race, practice setting, and employer policy on PDMP use. Among the 818 PDMP users, 396 (48%) used the database at least once during a shift. Frequent PDMP users were more likely to recommend naloxone compared with less frequent users (adjusted odds ratio 1.70 [95% CI 1.09-2.65], P = 0.02). The following 3 interview themes were identified: time, company policy, and red flags. CONCLUSION: PDMP has value to pharmacists of all practice settings studied. Frequent PDMP use may facilitate more pharmacist interventions, such as a naloxone prescription.","language":"eng","number":"1","journal":"Journal of the American Pharmacists Association: JAPhA","author":[{"propositions":[],"lastnames":["Pett"],"firstnames":["Ryan","G."],"suffixes":[]},{"propositions":[],"lastnames":["Mancl"],"firstnames":["Lloyd"],"suffixes":[]},{"propositions":[],"lastnames":["Revere"],"firstnames":["Debra"],"suffixes":[]},{"propositions":[],"lastnames":["Stergachis"],"firstnames":["Andy"],"suffixes":[]}],"month":"February","year":"2020","pmid":"31753615","keywords":"Adult, Controlled Substances, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Pharmacists, Prescription Drug Monitoring Programs, Washington, Young Adult","pages":"57–65","bibtex":"@article{pett_prescription_2020,\n\ttitle = {Prescription drug monitoring program use and utility by {Washington} {State} pharmacists: {A} mixed-methods study},\n\tvolume = {60},\n\tissn = {1544-3450},\n\tshorttitle = {Prescription drug monitoring program use and utility by {Washington} {State} pharmacists},\n\tdoi = {10.1016/j.japh.2019.09.016},\n\tabstract = {OBJECTIVES: To explore factors and situations that influence pharmacists to use the prescription drug monitoring program (PDMP) and to characterize actions taken by pharmacists after alarming scenarios from a PDMP query.\nDESIGN: Explanatory sequential 2-phase mixed-methods design: (1) cross-sectional Web-based survey of Washington State pharmacists followed by (2) interviews with purposefully selected respondents to explore statistically significant quantitative findings.\nSETTING AND PARTICIPANTS: The study was conducted in Washington State from September 2018 to February 2019. A total of 967 Washington State pharmacists from various practice settings, including inpatient and outpatient pharmacies, participated. Ten outpatient pharmacists were interviewed in the second phase.\nOUTCOME MEASURES: The pharmacists reported the frequency of PDMP use, opinion on the usefulness of PDMP, and action(s) taken after a concerning PDMP report.\nRESULTS: The usable response rate for pharmacists with a PDMP account was 17.6\\% (818/4659), and usable response rate for all pharmacists was 10.4\\% (967/9263). PDMP use varied by race, practice setting, and employer policy on PDMP use. Among the 818 PDMP users, 396 (48\\%) used the database at least once during a shift. Frequent PDMP users were more likely to recommend naloxone compared with less frequent users (adjusted odds ratio 1.70 [95\\% CI 1.09-2.65], P = 0.02). The following 3 interview themes were identified: time, company policy, and red flags.\nCONCLUSION: PDMP has value to pharmacists of all practice settings studied. Frequent PDMP use may facilitate more pharmacist interventions, such as a naloxone prescription.},\n\tlanguage = {eng},\n\tnumber = {1},\n\tjournal = {Journal of the American Pharmacists Association: JAPhA},\n\tauthor = {Pett, Ryan G. and Mancl, Lloyd and Revere, Debra and Stergachis, Andy},\n\tmonth = feb,\n\tyear = {2020},\n\tpmid = {31753615},\n\tkeywords = {Adult, Controlled Substances, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Pharmacists, Prescription Drug Monitoring Programs, Washington, Young Adult},\n\tpages = {57--65},\n}\n\n","author_short":["Pett, R. G.","Mancl, L.","Revere, D.","Stergachis, A."],"key":"pett_prescription_2020","id":"pett_prescription_2020","bibbaseid":"pett-mancl-revere-stergachis-prescriptiondrugmonitoringprogramuseandutilitybywashingtonstatepharmacistsamixedmethodsstudy-2020","role":"author","urls":{},"keyword":["Adult","Controlled Substances","Cross-Sectional Studies","Female","Humans","Male","Middle Aged","Pharmacists","Prescription Drug Monitoring Programs","Washington","Young Adult"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/groups/4755044/items?key=kE93HNi2EuWuVnze1T2AvXhL&format=bibtex&limit=100","dataSources":["mCdh2uT8ggWmiA3zu"],"keywords":["adult","controlled substances","cross-sectional studies","female","humans","male","middle aged","pharmacists","prescription drug monitoring programs","washington","young adult"],"search_terms":["prescription","drug","monitoring","program","use","utility","washington","state","pharmacists","mixed","methods","study","pett","mancl","revere","stergachis"],"title":"Prescription drug monitoring program use and utility by Washington State pharmacists: A mixed-methods study","year":2020}